Comparing the effectiveness of Metacognitive therapy (MCT), pharmacotherapy (SSRIs) and EEG biofeedback in Generalized Anxiety Disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017061233946N4

Enrollment

Registered

2017-08-27

Start date

2013-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety. Anxiety disorder, unspecified

Interventions

Intervention 1: 10 session MCT based on MCT Manual. Intervention 2: 50-100 mg sertraline 20-40 mg citalopram 8 week. Intervention 3: EEG Biofeedback: 15 session, Increase Alpha in occipital 15 sessio

Behavior

Treatment - Drugs

10 session MCT based on MCT Manual

50-100 mg sertraline 20-40 mg citalopram 8 week

EEG Biofeedback: 15 session, Increase Alpha in occipital 15 session, Increase theta in occipital

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : no medicine consumption 1 month before the intervention; age 18-50 years old; having a minimum grade education. Exclusion criteria: psychotic disorder; drug dependence.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Anxiety. Timepoint: Pretest, post test( 8 months later). Method of measurement: GAD-7 questionar.;Depression. Timepoint: Pretest, post test( 8 months later). Method of measurement: Beck Depression Inventory.	—

Secondary

Measure	Time frame
Alpha Amplitude. Timepoint: Pretest, post test ( 8 months later). Method of measurement: Baselin by Neuroffedback.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Dadashi

Zanjan University of Medical Sciences and Health Services

psy.mohsen@gmail.com+98 24 3378 9469

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026